IMMUCELL CORP /DE/ cotiza a 9.60 USD y tiene una capitalización bursátil de $87M. En los últimos 12 meses ha facturado $31M con un margen de flujo de caja libre del 4.4%. Cotiza a 20.7 veces su flujo de caja libre (P/FCF) y a un PER de 110.7. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
ImmuCell Corporation, an animal health company, develops, manufactures, and sells products that improves the health and productivity of dairy and beef cattle in the United States and internationally. It operates through two segments, Scours and Mastitis. The company offers First Defense, an orally delivered scours prev…
| Periodo | 2026-11 | 2026-08 | 2021-02 | 2020-11 |
|---|---|---|---|---|
| Real | — | — | $0.03 | $-0.04 |
| Estimado | — | — | $-0.04 | $-0.08 |
| Sorpresa | — | — | +175.0% | +50.0% |
| Métrica | ICCC | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | 41.4% | 57.0% | -15.6% |
| Operating Margin | 6.0% | -38.6% | +44.6% |
| Net Margin | -3.8% | -33.6% | +29.8% |
| FCF Margin | 4.4% | -13.9% | +18.3% |
| ROE | -3.8% | -40.4% | +36.6% |
| ROA | -2.5% | -32.0% | +29.6% |
| Current Ratio | 4.26 | 2.84 | +1.42 |
| Debt / Equity | 0.34 | 0.28 | +0.06 |